Aquaculture Vaccine Market is anticipated to grow up to USD 320.3 million by 2031 | Zoetis, Phibro Animal Health Corporation, Elanco, Merck & Co., Inc.

Aquaculture vaccines are vaccines that are used to protect fish, shellfish, and other aquatic animals from disease. Aquaculture is the farming of aquatic animals, and it is a growing industry worldwide. Aquaculture vaccines are used to prevent diseases that can decimate entire stocks of fish or shellfish, and they are an important tool for protecting the health of these animals. Aquaculture vaccines are typically administered via injection or immersion. Injection is the most common method of vaccination, and it is typically done with a needle and syringe. Immersion is a less common method, and it involves placing the fish or shellfish in a tank of water that contains the vaccine. Aquaculture vaccines are typically made from inactivated or attenuated (weakened) viruses, bacteria, or other pathogens.

Download Sample PDF Of This Report:
https://www.globalinsightservices.com/request-sample/GIS24336/?utm_id=1011

Market Trends and Drivers
Vaccination of farmed fish has significant benefits in combating viral and bacterial diseases with absence of undesirable side-effects of antibiotics. Also, overuse of antibiotics leads to development of resistance that ultimately leads to loss of aquaculture produce and significant economic losses. Currently, countries in Europe such as Norway have virtually stopped use of antibiotics in aquaculture practices. This has positively influenced the aquaculture vaccines market growth and lowering the risk of antibiotic resistance. Moreover, with introduction of DNA and subunit vaccines due to technological advancements, the adoption of aquaculture vaccines will increase as compared to antibiotics.

Major Players in the Global Aquaculture Vaccine Market
The key players in the market Zoetis, Phibro Animal Health Corporation, Elanco, Merck & Co., Inc., KBNP, CAVAC, Kyoto Biken Laboratories, Inc., Nisseiken Co., Ltd., Vaxxinova International BV, and HIPRA. among others.

Request Customization:
https://www.globalinsightservices.com/request-customization/GIS24336/?utm_id=1011

COVID-19 Impact
The spread of COVID-19 pandemic across the globe has impacted the aquaculture vaccine in industry negatively in 2020. This is attributed to increasing number of COVID-19 infections along with logistical disruption in supply chains. Furthermore, decrease in the production of aquaculture vaccines owing to the reduced workforce coupled with shifting trends to develop vaccine for COVID-19 infection has influence the market growth negatively in 2020 to certain extent. However, with consecutive second and third wave of COVID-19 infections in various countries, the market is set to observe a sluggish growth in the short-term period.

Recent Developments
In October 2022, Hyderabad-based Indian Immunologicals (IIL), a subsidiary of National Dairy Development Board (NDDB), has forayed into the aquaculture health segment with the launch of its products to serve the growing need in farmed shrimp and fish in the country.
In April 2021, ICAR-CIBA has launched a recombinant vaccine against viral nervous necrosis (VNN), in a milestone for aquaculture vaccine development in India.
In September 2020, Virbac announced the acquisition of range of tilapia vaccines from Ictyogroup, an animal health company specialized in R&D biology. In addition to this acquisition, the two companies signed a partnership agreement for the development of new vaccines and new formulations for the Aqua Virbac division. This agreement is expected to avail the complete and innovative range of tilapia vaccines in Africa, Asia and Latin America. This strategy enabled company to add value to its existing portfolio and expand their customer base in untapped economies.
In January 2020, Barramundi Asia, a Singapore based company announced a merger with compatriot Allergo Aqua. The merger aimed to bring in-house fingerling R&D vaccination. This strategy helped companies to maintain long-term business relations, thereby strengthening its market presence.

Procure Complete Report (PDF with Insights, Charts, Tables, and Figures)
https://www.globalinsightservices.com/checkout/single_user/GIS24336/?utm_id=1011

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.